InvestorsHub Logo
Followers 45
Posts 1684
Boards Moderated 0
Alias Born 11/28/2018

Re: None

Thursday, 08/05/2021 4:34:53 PM

Thursday, August 05, 2021 4:34:53 PM

Post# of 233052
Hodl on for the show. New variants new strains every week and all I know is Leronlimab blocks CCR-5 receptor. Could be the most beneficial trial in Brazil which once and for all should dispel the theory of proper dosage. Einstein was a genius and look who is running trial. Albert Einstein. Genius
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News